Arkolith/Insider Trading/MDGL/Form 4

Baker Bros. Advisors LP

DirectorMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Jun 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Grant(A)908—$0204K
Jun 17, 2026Grant(A)908—$01.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Grant(A)2K—$02K
Jun 17, 2026Grant(A)2K—$02K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-275800) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML